AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 271: H924-H930, 1996;
0363-6135/96 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jackson, T. S.
Right arrow Articles by Keaney, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jackson, T. S.
Right arrow Articles by Keaney, J. F., Jr

AJP - Heart and Circulatory Physiology, Vol 271, Issue 3 924-H930, Copyright © 1996 by American Physiological Society


ARTICLES

Vasodilatory properties of recombinant maxadilan

T. S. Jackson, E. Lerner, R. M. Weisbrod, M. Tajima, J. Loscalzo and J. F. Keaney Jr
Evans Memorial Department of Medicine, Boston University School of Medicine 02118, USA.

Maxadilan is a peptide from the salivary gland of the sand fly Lutzomyia longipalpis, a vector for leishmaniasis. Cutaneous injection of femtomolar quantities of maxadilan produces long-lasting erythema, making it the most potent vasodilator known. Isolated rabbit thoracic and abdominal aorta, carotid artery, and iliac artery demonstrated dose-dependent arterial relaxation in response to maxadilan with a mean effective concentration (EC50) of 2.7 +/- 1.5, 2.1 +/- 0.5, 2.6 +/- 0.4, and 1.9 +/- 0.5 nM, respectively. Maxadilan proved to be at least sevenfold more potent than nitroglycerin in each arterial bed (EC50 = 25 +/- 12, 32 +/- 9, 37 +/- 10, and 22 +/- 13 nM, respectively; P < 0.05 for each vs. maxadilan). Arterial relaxation to maxadilan was independent of endothelium and was equipotent in the thoracic and abdominal aorta, carotid artery, and iliac artery. Arterial relaxation to maxadilan was not inhibited by K(+)-channel antagonists, methylene blue, quinacrine, or ouabain. Maxadilan-mediated arterial relaxation was found to be adenosine 3',5'-cyclic monophosphate (cAMP) dependent, as it was potentiated by the phosphodiesterase inhibitors 3-isobutyl-1-methylxanthine and theophylline, and it was inhibited by the protein kinase A inhibitor H-89. Consistent with this observation, incubation of thoracic aorta with maxadilan (0.1 microM) produced a time-dependent increase in arterial cAMP content coincident with arterial relaxation. Using rabbit aortic smooth muscle cells, we also observed a time-dependent reduction in intracellular calcium in response to maxadilan. Thus these data indicate that maxadilan, a peptide from the sand fly salivary gland, is a potent vasodilator that reduces intracellular calcium through a cAMP-dependent mechanism.


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Huang, H. Xiao, J. M. Samii, J. A. Vita, and J. F. Keaney Jr.
Contrasting effects of thiol-modulating agents on endothelial NO bioactivity
Am J Physiol Cell Physiol, August 1, 2001; 281(2): C719 - C725.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Xu, J. A. Vita, and J. F. Keaney Jr
Ascorbic Acid and Glutathione Modulate the Biological Activity of S-Nitrosoglutathione
Hypertension, August 1, 2000; 36(2): 291 - 295.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
O. M. Shapira, A. Xu, G. S. Aldea, J. A. Vita, R. J. Shemin, and J. F. Keaney Jr
Enhanced Nitric Oxide-Mediated Vascular Relaxation in Radial Artery Compared With Internal Mammary Artery or Saphenous Vein
Circulation, November 9, 1999; 100 (2009): II-322 - II-327.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
O. M. Shapira, A. Xu, J. A. Vita, G. S. Aldea, N. Shah, R. J. Shemin, and J. F. Keaney Jr
NITROGLYCERIN IS SUPERIOR TO DILTIAZEM AS A CORONARY BYPASS CONDUIT VASODILATOR
J. Thorac. Cardiovasc. Surg., May 1, 1999; 117(5): 906 - 911.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Huang, J. A. Vita, R. C. Venema, and J. F. Keaney Jr.
Ascorbic Acid Enhances Endothelial Nitric-oxide Synthase Activity by Increasing Intracellular Tetrahydrobiopterin
J. Biol. Chem., June 2, 2000; 275(23): 17399 - 17406.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online